Rare Hematology News
Advertisement
Spotlight On
Diamond-Blackfan anemia
Diamond-Blackfan anemia is an inherited blood disorder that affects the ability of the bone marrow to produce red blood cells. It's characterized by pure red cell aplasia, meaning the bone marrow is unable to generate red blood cells, while other blood cell types are usually normal
Prevalence
600–1,000
US Estimated
800–1,200
Europe Estimated
Age of Onset
Infancy
ICD-10
D61.0
Inheritance Pattern
Autosomal dominant
Autosomal recessive
Mitochondrial/Multigenic
X-linked dominant
X-linked recessive
5 Facts you should know
FACT
Craniofacial anomalies, thumb malformations, and short stature are common physical features, often prompting genetic evaluation in infants with unexplained anemia
FACT
DBA typically presents within the first year of life as macrocytic anemia with reticulocytopenia and normal marrow cellularity but absent erythroid precursors
FACT
More than 50% of cases are linked to mutations in ribosomal protein genes (e.g., RPS19, RPL5), highlighting DBA as a ribosomopathy with defective ribosome biogenesis
FACT
Patients are at elevated risk for malignancies, including acute myeloid leukemia (AML), osteogenic sarcoma, and myelodysplastic syndromes, requiring long-term monitoring
FACT
Management includes corticosteroid therapy, chronic red blood cell transfusions, iron chelation, and hematopoietic stem cell transplantation, which offers curative potential in select cases
Interest over time
Google searches
Common signs & symptoms
Macrocytic anemia
low red blood cell counts
Congenital abnormalities
e.g., craniofacial, limb, cardiac defects
Failure to thrive
Pallor, fatigue, tachycardia
Increased risk of malignancies
especially MDS and leukemia
Elevated erythrocyte adenosine deaminase (eADA) levels
Current treatments
Corticosteroids
initial treatment to stimulate red blood cell production
Chronic red blood cell transfusions
the only curative therapy
Iron chelation therapy
to address iron overload
Hematopoietic stem cell transplant (HSCT)
potential cure in severe/transfusion-dependent cases